1Spellman CW. Pathophysiology of type 2 diabetes: targeting islet cell dysfunction[J]. J Am Osteopath Assoc, 2010, 110(3 Suppl 2): S2-S7.
2Lee J. Adipose tissue macrophages in the development of obesity- induced inflammation, insulin resistance and type 2 diabetes[J]. Arch Pharm Res, 2013, 36(2): 208-222.
3Defronzo RA, Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus[J]. Diabetes, 2009, 58(4): 773-795.
4Leibiger B, Leibiger IB, Moede T, et al. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells[J]. Mol Cell, 2001, 7(3): 559-570.
5Kooy A, de Jager J, Lehert P, et al. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus[J]. Arch Intern Med, 2009, 169(6): 616-625.
6Giugliano D, Quatraro A, Consoli G, et al. Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors[J]. Eur J Clin Pharmacol, 1993, 44 (2): 107-112.
7Cheng Q, Yang S, Zhao C, et al. Efficacy of metformin-based oral antidiabetic drugs is not inferior to insulin glargine in newly diagnosed type 2 diabetic patients with severe hyperglycemia after short-term intensive insulin therapy[J]. J Diabetes, 2014, doi: 10.1111.
8American Diabetes Association. Standards of medical care in diabetes 2014[J]. Diabetes Care, 2014, 37(Suppl 1): S14-80.
9Hemmingsen B, Christensen LL, Wetterslev J, et al. Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses[J]. Bri Med J, 2012, 344: e 1771.
10Mogensen UM, Andersson C, Fosbol EL, et al. Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and mettbrmin in a retrospective Danish nationwide study[J]. Diabetologia, 2015, 58(1): 50-58.
